A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 7, 2016, Pages 1069-1077

  Totte J E E ^a   van der Feltz, W T ^b   Bode, L G M ^c   van Belkum, A ^a,d   van Zuuren, E J ^e   Pasmans, S G M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d BIOMÉRIEUX   (France)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; BACTERIAL COLONIZATION; HUMAN; MUCOSA; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; ROSACEA; SKIN; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; ACNE VULGARIS; CASE CONTROL STUDY; COMPLICATION; HETEROZYGOTE; META ANALYSIS; MICROBIOLOGY; ODDS RATIO; STAPHYLOCOCCUS INFECTION;

ACNE VULGARIS; CARRIER STATE; CASE-CONTROL STUDIES; HUMANS; MUCOUS MEMBRANE; ODDS RATIO; PSORIASIS; ROSACEA; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84966429156     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2647-3     Document Type: Review

References (76)

1. Belkaid Y, Segre JA (2014) Dialogue between skin microbiota and immunity. Science 346(6212):954–959
2. Chen YE, Tsao H (2013) The skin microbiome: Current perspectives and future challenges. J Am Acad Dermatol 69(1):143–155
3. Sanford JA, Gallo RL (2013) Functions of the skin microbiota in health and disease. Semin Immunol 25(5):370–377
4. Kong HH, Segre JA (2012) Skin microbiome: looking back to move forward. J Invest Dermatol 132(3 Pt 2):933–939
5. Totte JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG (2016) Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol
6. Biedermann T, Skabytska Y, Kaesler S, Volz T (2015) Regulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous Inflammation. Front Immunol 6:353
7. Fry L, Baker BS (2007) Triggering psoriasis: the role of infections and medications. Clin Dermatol 25(6):606–615
8. Holmes AD (2013) Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol 69(6):1025–1032
9. Steinhoff M, Schauber J, Leyden JJ (2013) New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 69(6 Suppl 1):S15–26
10. Gollnick HPM (2015) From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol 29:1–7
11. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ (2008) Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One 3(7):e2719
12. Owen CM, Chalmers RJ, O’Sullivan T, Griffiths CE (2001) A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 145(6):886–890
13. Balci DD, Duran N, Ozer B, Gunesacar R, Onlen Y, Yenin JZ (2009) High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 19(3):238–242
14. Chong HT, Kopecki Z, Cowin AJ (2013) Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis. Biomed Res Int 2013:168321
15. Johannessen M, Sollid JE, Hanssen AM (2012) Host- and microbe determinants that may influence the success of S. aureus colonization. Front Cell Infect Microbiol 2:56
16. Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S (2014) Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 71(1):141–150
17. Mahajan R, Handa S (2013) Pathophysiology of psoriasis. Indian J Dermatol Venereol Leprol 79(Suppl 7):S1–9
18. van den Berg WB, McInnes IB (2013) Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 43(2):158–170
19. Atefi N, Tabaie M, Noorbakhsh S, Tabatabaie A, Rezaee M, Rohaninasab M (2012) The role of staphylococcus superantigens in chronic plaque type psoriasis. Iran J Dermatol 15(59):1–3
20. Leung DY, Walsh P, Giorno R, Norris DA (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100(3):225–228
21. Yamamoto T, Katayama I, Nishioka K (1998) Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris. Eur J Dermatol 8(5):325–329
22. Vazquez-Sanchez EA, Rodriguez-Romero M, Sanchez-Torres LE, Rodriguez-Martinez S, Cancino-Diaz JC, Rodriguez-Cortes O, Garcia-Lopez ES, Cancino-Diaz ME (2014) Peptidoglycan from Staphylococcus aureus has an anti-apoptotic effect in HaCaT keratinocytes mediated by the production of the cellular inhibitor of apoptosis protein-2. Microbiol Immunol 58(2):87–95
23. Bakry OA, Samaka RM, Sebika H, Seleit I (2014) Toll-like receptor 2 and P. acnes: do they trigger initial acne vulgaris lesions? Anal Quant Cytopathol Histpathol 36(2):100–110
24. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B (2014) Propionibacterium acnes: An update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol 28(3):271–278
25. Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B (2005) Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 153(6):1105–1113
26. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169(3):1535–1541
27. Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, Li H (2013) Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 133(9):2152–2160
28. Tomida S, Nguyen L, Chiu BH, Liu J, Sodergren E, Weinstock GM, Li H (2013) Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. MBio 4(3):e00003–00013
29. Jahns AC, Eilers H, Ganceviciene R, Alexeyev OA (2015) Propionibacterium species and follicular keratinocyte activation in acneic and normal skin. Brit J Dermatol 172(4):981–987
30. Jarmuda S, O’Reilly N, Zaba R, Jakubowicz O, Szkaradkiewicz A, Kavanagh K (2012) Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol 61(Pt 11):1504–1510
31. Koller B, Muller-Wiefel AS, Rupec R, Korting HC, Ruzicka T (2011) Chitin modulates innate immune responses of keratinocytes. PLoS One 6(2):e16594
32. Allen HB, Vaze ND, Choi C, Hailu T, Tulbert BH, Cusack CA, Joshi SG (2014) The presence and impact of biofilm-producing staphylococci in atopic dermatitis. JAMA Dermatol 150(3):260–265
33. Fournier B (2012) The function of TLR2 during staphylococcal diseases. Front Cell Infect Microbiol 2:167
34. Niebuhr M, Schorling K, Heratizadeh A, Werfel T (2015) Staphylococcal alpha-toxin induces a functional upregulation of TLR-2 on human peripheral blood monocytes. Exp Dermatol 24(5):381–383
35. Al Mishari MA (1987) Acne vulgaris: Treatment with tetracycline and its effect on bacterial flora. Curr Ther Res Clin Exp 41(3):351–355
36. Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5(3):e9836
37. Relman DA (2012) The human microbiome: ecosystem resilience and health. Nutr Rev 70(Suppl 1):S2–9
38. Leccia MT, Auffret N, Poli F, Claudel JP, Corvec S, Dreno B (2015) Topical acne treatments in Europe and the issue of antimicrobial resistance. J Eur Acad Dermatol Venereol 29:1485–92
39. Chon SY, Doan HQ, Mays RM, Singh SM, Gordon RA, Tyring SK (2012) Antibiotic overuse and resistance in dermatology. Dermatol Ther 25(1):55–69
40. World Health Organization (2001) Global Strategy for Containment of Antimicrobial Resistance. World Health Organization (WHO), Geneva
41. World Health Organization (2014) Antimicrobial resistance. Global report on surveillance: World Health Organization (WHO)
42. Knoll BM, Mylonakis E (2014) Antibacterial Bioagents Based on Principles of Bacteriophage Biology: An Overview. Clin Infect Dis 58(4):528–534
43. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
44. Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T (2014) The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol 134(6):1542–1551
45. McPheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, Andrews JC (2012) Quality improvement interventions to address health disparities. Closing the quality gap: revisiting the state of the science. Evidence Report No 208 (Prepared by the Vanderbilt University Evidence-based Practice Center under Contract No 290-2007-10065). Rockville, MD: Agency for healthcare research and quality
46. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
47. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
48. Tabatabaei A, Atefi N, Noorbakhsh S (2011) Staphylococcal superantigens in skin biopsy of psoriatic patients: A case control study. Allergy Eur J Allergy Clin Immunol 66:306
49. Tomi NS, Kranke B, Aberer E (2005) Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 53(1):67–72
50. Ryu JH, Lee J, Son SJ, Won YH, Oh JS (2003) Study of Bacterial Distribution on the Skin of Psoriasis by Tape Method. Korean J Dermatol 41(8):997–1003
51. Brook I, Frazier EH, Yeager JK (1999) Microbiology of infected pustular psoriasis lesions. Int J Dermatol 38(8):579–581
52. Sayama K, Midorikawa K, Hanakawa Y, Sugai M, Hashimoto K (1998) Superantigen production by Staphylococcus aureus in psoriasis. Dermatology 196(2):194–198
53. Noah PW (1990) The role of microorganisms in psoriasis. Semin Dermatol 9(4):269–276
54. Weissmann A, Noble WC (1980) Photochemotherapy of psoriasis: Effects on bacteria and surface lipids in uninvolved skin. Br J Dermatol 102(2):185–193
55. Aly R, Maibach HI, Mandel A (1976) Bacterial flora in psoriasis. Br J Dermatol 95(6):603–606
56. Andersen PS, Larsen LA, Fowler VG Jr, Stegger M, Skov RL, Christensen K (2013) Risk factors for Staphylococcus aureus nasal colonization in Danish middle-aged and elderly twins. Eur J Clin Microbiol Infect Dis 32(10):1321–1326
57. Klein PA, Greene WH, Fuhrer J, Clark RA (1997) Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 133(11):1463–1465
58. Singh G, Rao DJ (1978) Bacteriology of psoriatic plaques. Dermatologica 157(1):21–27
59. Ajib R, Janbazian L, Rahal E, Matar GM, Zaynoun S, Kibbi AG, Abdelnoor AM (2005) HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus. J Biomed Biotechnol 2005(4):310–315
60. Numata S, Akamatsu H, Akaza N, Yagami A, Nakata S, Matsunaga K (2014) Analysis of facial skin-resident microbiota in Japanese acne patients. Dermatology 228(1):86–92
61. Moon SH, Roh HS, Kim YH, Kim JE, Ko JY, Ro YS (2012) Antibiotic resistance of microbial strains isolated from Korean acne patients. J Dermatol 39(10):833–837
62. Hassanzadeh P, Bahmani M, Mehrabani D (2008) Bacterial resistance to antibiotics in acne vulgaris: An in vitro study. Indian J Dermatol 53(3):122–124
63. Williams RE, Doherty VR, Perkins W, Aitchison TC, Mackie RM (1992) Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 126(4):362–366
64. Leyden JJ, McGinley KJ, Foglia AN (1986) Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 86(4):390–393
65. Batova D, Hadam I (1971) Demonstration of skin microflora in patients with acne vulgaris. Cesk Dermatol 46(5):196–199
66. Ozuguz P, Callioglu EE, Tulaci KG, Kacar SD, Balta I, Asik G, Karatas S, Karaca S (2014) Evaluation of nasal and oropharyngeal flora in patients with acne vulgaris according to treatment options. Int J Dermatol 53(11):1404–1408
67. Basak PY, Cetin ES, Gurses I, Ozseven AG (2013) The effects of systemic isotretinoin and antibiotic therapy on the microbial floras in patients with acne vulgaris. J Eur Acad Dermatol Venereol 27(3):332–336
68. Toyne H, Webber C, Collignon P, Dwan K, Kljakovic M (2012) Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice. Australas J Dermatol 53(2):106–111
69. Khorvash F, Abdi F, Kashani HH, Naeini FF, Narimani T (2012) Staphylococcus aureus in Acne Pathogenesis: A Case–control Study. N Am J Med Sci 4(11):573–576
70. Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ (2011) Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol 147(8):917–921
71. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ (2003) Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 139(4):467–471
72. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5(12):751–762
73. Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA (2013) Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci U S A 110(37):15061–15066
74. Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9(4):244–253
75. Krishna S, Miller LS (2012) Host-pathogen interactions between the skin and Staphylococcus aureus. Curr Opin Microbiol 15(1):28–35
76. Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL (2013) The microbiome extends to subepidermal compartments of normal skin. Nat Commun 4:1431